Atom Limbs Raises $1.5M for Prosthetics

Here's Why I Angel-Invested $500 into Atom Limbs

🦾 Atom Limbs

Backed by Moai Capital, J4 Ventures, Village Global, angels including Trevor Blackwell and Anthony Pompliano, and countless healthcare professionals, Atom Limbs’ pioneering approach to the world's first artificial human arm is on track to transform the $800B+ physical disability industry.

🏃🏻 Rundown

  • One-Liner: The World’s 1st Artificial Arm

  • Based In: Menlo Park

  • Starting Year: 2022

  • Industry: Medtech, Hardware

  • Market: projected $1B in LTV

  • Business Model: B2C

  • Investment Round: $1.7M Seed

  • Early Traction: $180M+ pipeline of 9,000 qualified buyers

  • CEO sold last company Bebo to Amazon & has scaled companies to 1B users

founder story/problem/market-fit

More than 65M people in the world — including 4M in the United States — live without a limb. 1.5M people undergo amputation every single year. - By 2050, instances of limb loss are projected to double. Yet only 5% of people with limb loss have access to prosthetics, many of which still rely on technology that's over a century old, dating back to 1912!

  • Tyler Hayes - Serial entrepreneur. Bebo Co-Founder & COO (acquired by Amazon). Employee #10 at YC-backed Disqus (acquired by Zeta). Scaled companies from 0-100 employees and to 1 billion users. Funded by top VCs Village Global, MXB, and Techstars. Psychology BA.

  • Doug Satzger - Iconic product creator. Industrial Design Executive with history at Apple, Intel, Palm & IDEO. Led teams responsible for the first iMac & iPhone under CEO Steve Jobs, and managed entire iPod, iMac & iPad portfolio. Named on 500+ patents. Design BA.

  • Eric Monsef - Senior tech pioneer previously with Apple, HP & Glydways. Created Apple’s Core Hardware Team of 180 Deep Engineers, managed $250M budget & led architecture / design on the original MacBook & 11 MacBook Pros. Named on 40+ patents. Engineering BS, MS.

solution

Our first and flagship prototype, the Atom Touch, is the world's first artificial human arm. This groundbreaking, non-invasive, non-invasively neurally-controlled robotic system emulates a near-full range of human motion and even provides the user with basic touch feedback.

The control is made possible by sEMG and machine learning, powered by proprietary non-invasive electrodes placed on the residual limb. The incorporation of haptic feedback further refines the user’s overall control by providing touch sensations. Users can train the Atom Touch in less than 5 minutes.

Atom Touch stands alone as the only artificial hand that enables individual finger movement, making actions like grasping, gripping, feel natural again.

Our proprietary miniaturized motors, paired with our overall modular design, offers users both gross (elbow/wrist) and fine (fingers) control for human-like dexterity.

🧐 core business model

  • Paid B2C Model : $150k

  • 4 Growth Factors according to Blitzscaling:

    • Market Size

      • TAM = $800B

      • SAM = upper limb market accounts for $45B

      • SOM = expect $1M sold in the 1st year

    • Gross Margins: not inducing revenue yet

    • Distribution: “We aim for our arm to be reimbursed by healthcare payers. We also anticipate direct pay. This means we have to demonstrate to insurers, both private and public, that we're better than existing solutions by demonstrating improved outcomes. We're mitigating this risk by gathering clinical data to support this during our clinical trial process; this is very typical among medical devices.“

    • Network Effects: product-led referrals.

  • 2 Growth Limiters according to Blitzscaling:

    • Lack of Product-Market Fit (PMF): Lack of PMF is hardly going to be a problem with a soaring market and great user feedback.

    • Operational Scalability: As they scale, they will have to take care of or outsource distribution. This is hardware nevertheless. We aim for our arm to be reimbursed by healthcare payers. We also anticipate direct pay. This means we have to demonstrate to insurers, both private and public, that we're better than existing solutions by demonstrating improved outcomes. We're mitigating this risk by gathering clinical data to support this during our clinical trial process; this is very typical among medical devices.

🏆 AI competitive advantage

  1. Model builders, model integrators, or vertical enterprise players? Model builders. They have built their own proprietary machine learning models to train individual arm signaling.

  2. Data Strategy: Their models scale as they scale.

  3. Direct access to customers? Yes!

🫂 why people love it

💸 why you will too!

  •  🙏 Future Category King: Atom Limbs is a future category king in arm prosthetics development with high praise from its users and high waitlist traction from over 9000 people.

  • 📈 Super Experienced Team: Serial Entrepreneur Tyler Hayes sold 3 Businesses(Bebo to Amazon), claims Atom to be his “life-mission” company. 2 designers led Apple’s Mac and iPad designs.

  • ⬆️ Traction: Atom Limbs secured $180M+ pipeline of 9,000 qualified buyers

Reply

or to participate.